| Literature DB >> 27685941 |
Elena Chiappini1, Francesco Vierucci2, Francesca Ghetti1, Maurizio de Martino1, Luisa Galli1.
Abstract
OBJECTIVES: To evaluate vitamin D status in internationally adopted children at first medical evaluation in Italy and to identify possible risk factors for hypovitaminosis D in this population.Entities:
Year: 2016 PMID: 27685941 PMCID: PMC5042493 DOI: 10.1371/journal.pone.0158469
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the 962 internationally adopted children included in the study.
| Age at blood evaluation, years | 5.47 (3.14–7.93) |
| Age at adoption, years | 5.23 (2.93–7.60) |
| Time spent in Italy before evaluation, days | 72 (47–110) |
| Height/length, Z-score | -0.50 (-1.27; 0.39) |
| BMI, Z-score | -0.05 (-0.88; 0.72) |
| < 6 years | 530/962 (55.09) |
| ≥ 6 years | 432/962 (44.91) |
| Male | 581/962 (60.40) |
| Female | 381/962 (39.60) |
| < 3 months | 639/962 (66.42) |
| ≥ 3 months | 323/962 (33.58) |
| Winter (Jan–Mar) | 237/962 (24.64) |
| Spring (Apr–Jun) | 241/962 (25.05) |
| Summer (Jul–Sep) | 245/962 (25.47) |
| Fall (Oct–Dec) | 239/962 (24.84) |
| Africa | 174/962 (18.09) |
| South America | 206/962 (21.41) |
| Asia | 157/962 (16.32) |
| Europe | 425/962 (44.18) |
Vitamin D status in internationally adopted children divided for country of origin.
| Severe vitamin D deficiency, n (%) | Vitamin D deficiency, n (%) | Hypovitaminosis D, n (%) | Vitamin D sufficiency, n (%) | |
|---|---|---|---|---|
| Burkina Faso (n = 20) | 1 (5.0) | 12 (60.0) | 17 (85.0) | 3 (15.0) |
| Congo (n = 42) | 2 (4.8) | 13 (30.9) | 28 (66.7) | 14 (33.3) |
| Ethiopia (n = 90) | 13 (14.4) | 49 (54.4) | 78 (86.7) | 12 (13.3) |
| Other countries (n = 22) | 0 (0.0) | 3 (13.6) | 14 (63.6) | 8 (36.4) |
| Brazil (n = 43) | 2 (4.6) | 16 (37.2) | 27 (57.1) | 16 (37.2) |
| Chile (n = 43) | 5 (11.6) | 18 (41.9) | 38 (88.4) | 5 (11.6) |
| Colombia (n = 78) | 2 (2.6) | 25 (32.0) | 58 (74.4) | 20 (25.6) |
| Peru (n = 28) | 5 (17.9) | 19 (67.9) | 25 (89.3) | 3 (10.7) |
| Other countries (n = 14) | 0 (0.0) | 1 (7.1) | 9 (64.3) | 5 (35.7) |
| China (n = 27) | 0 (0.0) | 5 (18.5) | 20 (74.1) | 7 (25.9) |
| Philippines (n = 14) | 0 (0.0) | 4 (28.6) | 11 (78.6) | 3 (21.4) |
| India (n = 55) | 15 (27.3) | 41 (74.5) | 50 (90.9) | 5 (9.1) |
| Vietnam (n = 37) | 0 (0.0) | 4 (10.8) | 12 (32.4) | 25 (67.6) |
| Other countries (n = 24) | 4 (16.7) | 9 (37.5) | 13 (54.2) | 11 (45.8) |
| Bulgaria (n = 29) | 9 (31.0) | 18 (62.1) | 26 (89.7) | 3 (10.3) |
| Lithuania (n = 10) | 2 (20.0) | 4 (40.0) | 9 (90.0) | 1 (10.0) |
| Poland (n = 21) | 0 (0.0) | 6 (28.6) | 14 (66.7) | 7 (33.3) |
| Russia (n = 281) | 29 (10.3) | 113 (40.2) | 198 (70.5) | 83 (29.5) |
| Ukraine (n = 43) | 2 (4.6) | 12 (27.9) | 29 (67.4) | 14 (32.6) |
| Hungary (n = 26) | 0 (0.0) | 8 (30.8) | 20 (76.9) | 6 (23.1) |
| Other countries (n = 15) | 1 (6.7) | 8 (53.3) | 13 (86.7) | 2 (13.3) |
Serum 25(OH)D levels [median (IQR)] and vitamin D status related to presumed risk factors for hypovitaminosis D.
| n/tot (%) | 25(OH)D, ng/mL | p | n/tot (%) with severe deficiency (<10 ng/dL) | p | n/tot (%) with deficiency (<20 ng/dL) | p | n/tot (%) with hypovitaminosis D (<30 ng/dL) | p | |
|---|---|---|---|---|---|---|---|---|---|
| Entire sample | 962/962 (100%) | 22.0 (15.0–30.0) | 92/962 (9.56) | 388/962 (40.33) | 710/962 (73.80) | ||||
| 0.226 | |||||||||
| < 6 years | 530/962 (55.09) | 24.0 (16.0–32.2) | 45/530 (8.49) | 183/530 (34.53) | 354/530 (66.79) | ||||
| ≥ 6 years | 432/962 (44.91) | 20.0 (13.0–26.7) | 47/432 (10.88) | 205/432 (47.45) | 356/432 (82.41) | ||||
| 0.819 | 0.823 | 0.271 | 0.231 | ||||||
| Male | 581/962 (60.40) | 22.0 (15.0–29.0) | 57/581 (9.81) | 232/581 (39.93) | 437/581 (75.22) | ||||
| Female | 381/962 (39.60) | 22.0 (14.0–31.0) | 35/381 (9.19) | 156/381 (40.94) | 273/381 (71.65) | ||||
| < 3 months | 639/962 (66.42) | 23.0 (16.0–32.0) | 50/639 (7.82) | 238/639 (37.24) | 439/639 (68.70) | ||||
| ≥ 3 months | 323/962 (33.58) | 20.0 (12.7–26.0) | 42/323 (13.00) | 150/323 (46.43) | 271/323 (83.90) | ||||
| Winter (Jan–Mar) | 237/962 (24.64) | 15.0 (10.0–23.0) | 52/237 (21.94) | 158/237 (66.67) | 202/237 (85.23) | ||||
| Spring (Apr–Jun) | 241/962 (25.05) | 20.0 (14.0–26.0) | 21/241 (8.71) | 108/241 (44.81) | 205/241 (85.06) | ||||
| Summer (Jul–Sep) | 245/962 (25.47) | 31.0 (24.0–39.0) | 2/245 (0.82) | 29/245 (11.84) | 113/245 (46.12) | ||||
| Fall (Oct–Dec) | 239/962 (24.84) | 22.0 (16.0–28.0) | 17/239 (7.11) | 93/239 (38.91) | 190/239 (79.5) | ||||
| 0.595 | 0.366 | 0.207 | 0.103 | ||||||
| Africa | 174/962 (18.09) | 21.0 (14.0–28.2) | 16/174 (9.20) | 77/174 (44.25) | 137/174 (78.74) | ||||
| South America | 206/962 (21.41) | 22.0 (16.0–29.0) | 14/206 (6.80) | 79/206 (38.35) | 157/206 (76.21) | ||||
| Asia | 157/962 (16.32) | 23.0 (13.5–33.0) | 19/157 (12.1) | 63/157 (40.13) | 106/157 (67.52) | ||||
| Europe | 425/962 (44.18) | 23.0 (14.0–30.0) | 43/425 (10.12) | 169/425 (39.76) | 310/425 (72.94) | ||||
| 0.400 | 0.897 | 0.483 | 0.638 | ||||||
| < -2 | 70/962 (7.28) | 22.0 (14.0–31.0) | 7/70 (10.07) | 31/70 (44.29) | 50/70 (71.42) | ||||
| ≥ -2 | 892/962 (92.72) | 21.0 (14.0–28.0) | 85/892 (9.52) | 357/892 (40.02) | 660/892 (73.99) | ||||
| 0.544 | 0.812 | 0.312 | 0.151 | ||||||
| Positive | 291/962 (30.25) | 22.0 (14.0–29.0) | 29/291 (9.97) | 120/291 (41.24) | 224/291 (76.98) | ||||
| Negative | 671/962 (69.75) | 23.0 (15.0–30.0) | 63/671 (9.39) | 268/671 (39.94) | 486/671 (72.43) | ||||
| 0.189 | 0.436 | 0.378 | 0.228 | ||||||
| Positive | 46/962 (4.78) | 20.5 (11.7–26.0) | 6/46 (13.04) | 21/46 (45.65) | 38/46 (82.61) | ||||
| Negative | 916/962 (95.22) | 22.0 (15.0–30.0) | 86/916 (9.39) | 367/916 (40.07) | 672/916 (73.36) |
Multiple logistic regression for presumed risk factors for severe vitamin D deficiency, vitamin D deficiency and hypovitaminosis D.
| Severe vitamin D deficiency | Vitamin D deficiency | Hypovitaminosis D | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25(OH)D < 10 ng/mL | 25(OH)D < 20 ng/mL | 25(OH)D < 30 ng/mL | ||||||||||
| B (SE) | aOR | 95%CI | p | B (SE) | aOR | 95%CI | p | B (SE) | aOR | 95%CI | p | |
| (female vs male | 0.07 (0.24) | 1.07 | 0.67–1.73 | 0.771 | 0.11 (0.15) | 1.11 | 0.83–1.50 | 0.474 | -0.22 (0.17) | 0.81 | 0.58–1.12 | 0.203 |
| ≥ 6 years vs < 6 | 0.23 (0.24) | 1.26 | 0.79–2.01 | 0.340 | 0.63 (0.15) | 1.87 | 1.39–2.52 | 0.92 (0.18) | 2.50 | 1.77–3.53 | ||
| ≥ 3 months vs < 3 | 0.44 (0.24) | 1.56 | 0.97–2.49 | 0.065 | 0.07 (0.16) | 1.07 | 0.78–1.48 | 0.656 | 0.57 (0.20) | 1.77 | 1.21–2.61 | |
| Summer | 2.27 (0.75) | 1 (reference) | 2.20–42.38 | 1.60 (0.24) | 1 (reference) | 3.07–7.94 | 1.59 (0.22) | 1 (reference) | 3.20–7.47 | |||
| Fall | 3.65 (0.73) | 9.66 | 9.11–161.67 | 2.79 (0.25) | 4.94 | 9.94–26.64 | 1.88 (0.24) | 4.89 | 4.10–10.48 | |||
| Winter | 2.49 (0.75) | 38.38 | 2.79-52-45 | 1.78 (0.24) | 16.27 | 3.69–9.48 | 1.91 (0.23) | 6.56 | 4.31–10.71 | |||
| Spring | 12.11 | 5.92 | 6.79 | |||||||||
| not-Europe vs Europe | 0.01 (0.24) | 1.00 | 0.63–1.60 | 0.988 | 0.19 (0.15) | 1.21 | 0.90–1.63 | 0.204 | 0.27 (0.17) | 1.31 | 0.94–1.83 | 0.105 |
| BMI Z-score | ||||||||||||
| (< -2 vs ≥ -2) | -0.20 (0.53) | 0.81 | 0.29–2.28 | 0.698 | -0.01 (0.35) | 0.99 | 0.50–1.96 | 0.970 | -0.22 (0.39) | 0.80 | 0.38–1.72 | 0.573 |
| χ2 = 91.06, p<0.0001; Cox R2 = 0.090; Nagelkerke R2 = 0.193;Hosmer and Lemeshow test p = 0.663 | χ2 = 197.66, p<0.0001; Cox R2 = 0.186; Nagelkerke R2 = 0.251;Hosmer and Lemeshow test p = 0.223 | χ2 = 188.02, p<0.0001; Cox R2 = 0.178; Nagelkerke R2 = 0.260;Hosmer and Lemeshow test p = 0.099 | ||||||||||
Note. Adjusted for year of blood sample. C.I.: Coefficient Interval